- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 04-11-2025: Press Release
04-11-2025 | 02:36 pm
04-11-2025 | 02:36 pm
Zydus Lifesciences has received tentative USFDA approval for Budesonide delayed-release capsules (4 mg) to treat mild to moderate Crohn's disease. This expands their product pipeline for the US market.
No comments yet. Be the first to comment!